ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 88916 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 88916; 2) Community: the network communities that were significantly associated with the response to NSC 88916; 3) Molecule: the relationships between components within communities and NSC 88916; 4) MDR: the compounds that were significantly associated with the NSC 88916.

NSC Compound Enrichment Correlation
NSC 722781 trans-bis(acetato)amminepyridineplatinum(II) 0.0385613993886001 0.22720052
NSC 722854 1,4-di-N-oxide-2-phenylcarbonyl-3-trifluoromethylquinoxaline 0.0385613993886001 0.45390664
NSC 730868 (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one 0.0385613993886001 0.38445384
NSC 732178 Null 0.0385613993886001 0.10539058
NSC 733504 Everolimus 0.0385613993886001 -0.024048177
NSC 735373 Bis{(5,6-dihydro-5,11-diketo-2,3-dimethoxy-11H-indeno[1,2-c] isoquinoline)-6-propylamino}propane Bis(trifluoroacetate) 0.0385613993886001 0.13153787
NSC 736041 7-(5-diethylaminopentyloxy)-5-hydroxy-2-phenyl-4H-4-chromeno ne 0.0385613993886001 0.12975236
NSC 736802 Null 0.0385613993886001 0.31724197
NSC 740 Methotrexate 0.0385613993886001 0.29656877
NSC 740024 4-(2-Benzylthio-4-chloro-5-methylbenzenesulfonyl)-5,7-dimeth yl-2,4-dihydro-[1,2,4]triazepin-3-ylideneamine 0.0385613993886001 0.57917139
Total:94  Current:79    [First] [Prev] [Next] [Last]